Low level of antifungal resistance of Candida glabrata blood isolates in Turkey: Fluconazole minimum inhibitory concentration and FKS mutations can predict therapeutic failure

BACKGROUND: Candida glabrata is the third leading cause of candidaemia in Turkey; however, the data regarding antifungal resistance mechanisms and genotypic diversity in association with their clinical implication are limited. OBJECTIVES: To assess genotypic diversity, antifungal susceptibility and...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Mycoses
Hlavní autoři: Arastehfar, Amir, Daneshnia, Farnaz, Salehi, Mohammadreza, Yaşar, Melike, Hoşbul, Tuğrul, Ilkit, Macit, Pan, Weihua, Hagen, Ferry, Arslan, Nazlı, Türk‐Dağı, Hatice, Hilmioğlu‐Polat, Süleyha, Perlin, David S., Lass‐Flörl, Cornelia
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley and Sons Inc. 2020
Témata:
Original Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7497236/
https://ncbi.nlm.nih.gov/pubmed/32413170
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/myc.13104
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky